跳至主要内容
临床试验/JPRN-UMIN000011823
JPRN-UMIN000011823招募中未知

Phase II study of more than second-line Nab-PTX for advanced non-small cell lung cancer which is previously treated with chemotherapy - Phase II Study of more than 2nd line Nab-PTX for NSCLC

Incorporated Administrative Agency National Hospital Organization Nishigunma National Hospital0 个研究点目标入组 37 人开始时间: 2013年9月20日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
37

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Symptomatic brain metastasis 2) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy 3) With active double cancer or multicentric cancer 4) The peripheral sense neuropathy is Grade2 or more by CTCAE at registration. 5) Treated with radiotherapy within the past four weeks. 6) With a history of the treatment with Paclitaxel. 7) With clinically important complications. 8) Interstitial pneumonia or pulmonary fibrosis becomes the clinical problem 9) With pleural effusion or pericardial effusion accumulates which need drainage 10) With the history of hypersensivity for paclitaxel or albumin 11) Main organs had a serious medical risk factor, and the physicians judged treatment not to be safe. 12) Physician concludes that the patient's participation in this trial is inappropriate

研究者

发起方
Incorporated Administrative Agency National Hospital Organization Nishigunma National Hospital

相似试验